Janus Henderson Group’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.3M | Buy |
751,562
+431,733
| +135% | +$9.37M | 0.01% | 609 |
|
|
2025
Q1 | $7.9M | Sell |
319,829
-156,194
| -33% | -$3.86M | ﹤0.01% | 756 |
|
|
2024
Q4 | $9.94M | Buy |
476,023
+115,832
| +32% | +$2.42M | 0.01% | 733 |
|
|
2024
Q3 | $7.16M | Sell |
360,191
-1,815,450
| -83% | -$36.1M | ﹤0.01% | 769 |
|
|
2024
Q2 | $33.7M | Sell |
2,175,641
-550,747
| -20% | -$8.53M | 0.02% | 467 |
|
|
2024
Q1 | $43.4M | Buy |
2,726,388
+1,587,794
| +139% | +$25.3M | 0.02% | 418 |
|
|
2023
Q4 | $19.1M | Buy |
1,138,594
+730,695
| +179% | +$12.3M | 0.01% | 561 |
|
|
2023
Q3 | $4.77M | Buy |
407,899
+101,392
| +33% | +$1.19M | ﹤0.01% | 832 |
|
|
2023
Q2 | $4.12M | Buy |
306,507
+263,116
| +606% | +$3.54M | ﹤0.01% | 919 |
|
|
2023
Q1 | $720K | Buy |
43,391
+23,375
| +117% | +$388K | ﹤0.01% | 1810 |
|
|
2022
Q4 | $372K | Sell |
20,016
-20,018
| -50% | -$372K | ﹤0.01% | 1866 |
|
|
2022
Q3 | $514K | Sell |
40,034
-23,430
| -37% | -$301K | ﹤0.01% | 1932 |
|
|
2022
Q2 | $445K | Sell |
63,464
-60,356
| -49% | -$423K | ﹤0.01% | 1836 |
|
|
2022
Q1 | $1.03M | Sell |
123,820
-33,727
| -21% | -$280K | ﹤0.01% | 1489 |
|
|
2021
Q4 | $1.07M | Buy |
157,547
+14,259
| +10% | +$96.6K | ﹤0.01% | 1484 |
|
|
2021
Q3 | $759K | Sell |
143,288
-26,775
| -16% | -$142K | ﹤0.01% | 1439 |
|
|
2021
Q2 | $978K | Buy |
+170,063
| New | +$978K | ﹤0.01% | 1330 |
|